{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T12:17:57Z","timestamp":1795263477420,"version":"4.10.3"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ijgc-2021-003001","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T05:30:11Z","timestamp":1646631011000},"page":"436-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":223,"title":["Global challenges of radiotherapy for the treatment of locally advanced cervical cancer"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"nct04070976","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04583254","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jyoti S","family":"Mayadev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Mahantshetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos David","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-5093","authenticated-orcid":false,"given":"Rafal","family":"Tarnawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Toita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-003001_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2021-003001_bb0015","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1136\/ijgc-2021-003001_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143 Suppl 2","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2021-003001_bb0025","first-page":"287","article-title":"The new (version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer","volume":"71","author":"Olawaiye","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2021-003001_bb0030","author":"Oncology NEWS International","year":"1999","journal-title":"NCI urges chemo-RT combination for invasive cervical cancer"},{"key":"10.1136\/ijgc-2021-003001_bb0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2017.01.033","article-title":"Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis","volume":"145","author":"Datta","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","article-title":"Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial","volume":"4","author":"Shrivastava","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-003001_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2018.04.563","article-title":"Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California","volume":"150","author":"Mayadev","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0060","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/ajco.12605","article-title":"Assessing guideline adherence and patient outcomes in cervical cancer","volume":"13","author":"Chiew","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0065","article-title":"From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience","volume":"13","author":"Espenel","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0070","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e83","article-title":"Quality indicators for cervical cancer care in Japan","volume":"29","author":"Watanabe","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.prro.2016.01.012","article-title":"Radiation therapy quality-of-care indicators for locally advanced cervical cancer: a consensus guideline","volume":"6","author":"Croke","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0080","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2019.03.020","article-title":"Importance of technique, target selection, contouring, dose prescription, and dose-planning in external beam radiation therapy for cervical cancer: evolution of practice from EMBRACE-I to II","volume":"104","author":"Berger","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-003001_bb0085","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-016-0508-y","article-title":"Brachytherapy in gynecologic cancers: why is it underused?","volume":"18","author":"Han","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1136\/ijgc-2021-003001_bb0095","first-page":"4","article-title":"Brachytherapy: halting the spiral of decline","volume":"85","author":"Fricker","year":"2019","journal-title":"Cancerworld"},{"key":"10.1136\/ijgc-2021-003001_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2016.09.009","article-title":"Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer","volume":"143","author":"Robin","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2017.09.004","article-title":"Evaluation of delivery costs for external beam radiation therapy and brachytherapy for locally advanced cervical cancer using time-driven activity-based costing","volume":"100","author":"Bauer-Nilsen","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-003001_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.brachy.2018.12.002","article-title":"Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer","volume":"18","author":"Ma","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jrr\/rry035","article-title":"National survey of intracavitary brachytherapy for intact uterine cervical cancer in Japan","volume":"59","author":"Toita","year":"2018","journal-title":"J Radiat Res"},{"key":"10.1136\/ijgc-2021-003001_bb0120","article-title":"Radiation oncology's role in the next chapter of payment reform","volume":"27","author":"Hubbard","year":"2021","journal-title":"Am J Manag Care"},{"key":"10.1136\/ijgc-2021-003001_bb0125","author":"Borras","year":"2020","journal-title":"Tackling reimbursement for radiation oncology and cancer surgery: challenges and options (last updated 10 Jul 2020)"},{"key":"10.1136\/ijgc-2021-003001_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/jcb.2020.92765","article-title":"Can brachytherapy be properly considered in the clinical practice? Trilogy project: the vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group","volume":"12","author":"Tagliaferri","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brachy.2020.07.003","article-title":"#ThisIsBrachytherapy: increasing awareness of brachytherapy","volume":"20","author":"Kahn","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0140","author":"Petereit","year":"2019","journal-title":"Moving forward: 300 in 10: the American Brachytherapy Society\u2019s 10-year training strategy. ASTROnews. Spring"},{"key":"10.1136\/ijgc-2021-003001_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brachy.2020.08.022","article-title":"Simulation-based learning for enhanced gynecologic brachytherapy training among radiation oncology residents","volume":"20","author":"Williams","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.brachy.2020.07.015","article-title":"Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives","volume":"19","author":"Abdel-Wahab","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5114\/jcb.2020.96873","article-title":"Brachytherapy in cervical cancer radiotherapy during COVID-19 pandemic crisis: problems and prospects","volume":"12","author":"Miriyala","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0160","article-title":"Strategies to maximize available resources with minimum cost escalation for improving radiation therapy accessibility in the post-coronavirus disease 2019 era: an analysis for Asia","volume":"6","author":"Datta","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2014.02.018","article-title":"Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal\/epidural anesthesia: incidence and risk factors","volume":"89","author":"Kirchheiner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-003001_bb0170","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0175","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijrobp.2014.03.002","article-title":"Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020","volume":"89","author":"Datta","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-003001_bb0180","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2018.06.046","article-title":"Radiation therapy availability in Africa and Latin America: two models of low and middle income countries","volume":"102","author":"Bishr","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-003001_bb0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semradonc.2016.11.007","article-title":"Radiation oncology in India: challenges and opportunities","volume":"27","author":"Grover","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semradonc.2016.11.008","article-title":"Perspectives on patient access to radiation oncology facilities and services in mainland China","volume":"27","author":"Wang","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gore.2017.06.012","article-title":"Patterns of cervical cancer care in Argentina: applying ASCO recommendations adjusted by local resources","volume":"21","author":"Ap\u00e1s P\u00e9rez De Nucci","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2021-003001_bb0200","first-page":"1","article-title":"External radiation and brachytherapy resource deficit for cervical cancer in India: call to action for treatment of all","volume":"5","author":"Chopra","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacr.2011.07.014","article-title":"Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency","volume":"8","author":"Abdel-Wahab","year":"2011","journal-title":"J Am Coll Radiol"},{"key":"10.1136\/ijgc-2021-003001_bb0210","author":"International Atomic Energy Agency","year":"2017","journal-title":"Radiotherapy in cancer care: facing the global challenge"},{"key":"10.1136\/ijgc-2021-003001_bb0215","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/ajco.13310","article-title":"Experiences of barriers and facilitators to establishing and sustaining radiotherapy services in low- and middle-income countries: a qualitative study","volume":"16","author":"Donkor","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.37549\/ARO1193","article-title":"The global radiation oncology workforce in 2030: estimating physician training needs and proposing solutions to scale up capacity in low- and middle-income countries","volume":"8","author":"Elmore","year":"2019","journal-title":"Appl Rad Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijrobp.2018.07.2003","article-title":"Utilization of a web-based conferencing platform to improve global radiation oncology education and quality-proof of principle through implementation in India","volume":"103","author":"Robin","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-003001_bb0230","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.LBA3","article-title":"Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: the randomized phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)","volume":"39","author":"Mileshkin","year":"2021","journal-title":"JCO"},{"key":"10.1136\/ijgc-2021-003001_bb0235","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtho.2020.12.015","article-title":"Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial","volume":"16","author":"Faivre-Finn","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0240","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-003001_bb0245","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ijgc-2019-001135","article-title":"CALLA: efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study","volume":"30","author":"Mayadev","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-003001_bb0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/ijgc-2019-001012","article-title":"Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer","volume":"30","author":"Mayadev","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-003001_bb0255","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1002\/cncr.33136","article-title":"Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer","volume":"126","author":"Duska","year":"2020","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-003001_bb0260","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1136\/ijgc-2021-003001_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00149","article-title":"Triapine radiochemotherapy in advanced stage cervical cancer","volume":"8","author":"Kunos","year":"2018","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0270","article-title":"AGuIX\u00ae from bench to bedside-transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine","volume":"92","author":"Lux","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1136\/ijgc-2021-003001_bb0275","author":"International Atomic Energy Agency","year":"2013","journal-title":"Management of cervical cancer: strategies for limited-resource centres - a guide for radiation oncologists (last updated 19 Feb 2020)"},{"key":"10.1136\/ijgc-2021-003001_bb0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JGO.2016.003954","article-title":"Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline","volume":"2","author":"Chuang","year":"2016","journal-title":"J Glob Oncol"},{"key":"10.1136\/ijgc-2021-003001_bb0285","first-page":"S153","article-title":"Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer","volume":"131 Suppl 2","author":"Shrivastava","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2021-003001_bb0290","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brachy.2016.10.007","article-title":"American Brachytherapy Society: brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries","volume":"16","author":"Suneja","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-003001_bb0295","first-page":"1","article-title":"National cancer grid of India consensus guidelines on the management of cervical cancer","volume":"31","author":"Chopra","year":"2018","journal-title":"J Glob Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-003001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:45Z","timestamp":1753234125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24006170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1048891X24006170"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-003001","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global challenges of radiotherapy for the treatment of locally advanced cervical cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-003001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/.","name":"copyright","label":"Copyright"}]}}